Literature DB >> 25631652

Editorial: Betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease - authors' reply.

W Wang1, S Indik, G K-S Wong, A L Mason.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25631652      PMCID: PMC4329381          DOI: 10.1111/apt.13082

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


× No keyword cloud information.
We thank Tabibian and Lindor for their comments on our article.1,2 There are multiple challenges for establishing a pathogenic role for human betaretrovirus (HBRV) in primary biliary cirrhosis (PBC). Immune-based diagnostics are clearly required for conducting large-scale epidemiological studies, for example. Also, methods to measure low-level viral infection are necessary to link clinical improvement with diminished viral load in clinical trials of combination anti-viral therapy in PBC.3 Digital droplet PCR has shown promise in this area but linker-mediated PCR and next generation sequencing methods used in this study are too expensive and cumbersome.2 The concern that HBRV infection may just be an epiphenomenon is lessened somewhat by the association of viral infection with the mitochondrial phenotype observed in patients with PBC. The aberrant mitochondrial protein expression in virally infected biliary epithelium and lymph nodes has been documented in PBC patients4 and mouse models of autoimmune biliary disease.5 We agree that genetic susceptibility is probably a major factor that impacts on the development and extent of disease following infection. Indeed, the related agent, mouse mammary tumour virus (MMTV) is associated with a variety of inflammatory and neoplastic disorders in mice (lymphoma, breast and renal cancer) manifesting in different genetic backgrounds.5 Of relevance to detecting HBRV in normal individuals, diverse strains of mice have developed various mechanisms to control MMTV infection. For example, I/LnJ mice produce robust and sustained interferon-γ responses following MMTV infection and make neutralising antibodies that prevent viral spread.6 This may be of relevance to the viral hypothesis of PBC, as many genes within the IL-12 axis upstream of interferon-γ production have been implicated in genome-wide association studies as providing risk for the development of disease.7 Thus, further examination of the interaction of betaretrovirus infection with specific disease associated alleles is warranted to provide mechanistic insight how HBRV may become pathogenic in PBC patients.
  7 in total

1.  Letter: biochemical response to combination anti-retroviral therapy in patients with primary biliary cirrhosis.

Authors:  A L Mason; A J Montano-Loza; L Saxinger
Journal:  Aliment Pharmacol Ther       Date:  2014-01       Impact factor: 8.171

2.  Editorial: Betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease.

Authors:  J H Tabibian; K D Lindor
Journal:  Aliment Pharmacol Ther       Date:  2015-03       Impact factor: 8.171

3.  Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models.

Authors:  Guangzhi Zhang; Min Chen; Don Graham; Benchamas Subsin; Chelsea McDougall; Suzanna Gilady; Mark Kneteman; Lok Law; Mark Swain; Michael Trauner; Stephen Wrzesinski; Richard Flavell; Shawn Wasilenko; Andrew Mason
Journal:  J Hepatol       Date:  2011-02-18       Impact factor: 25.083

Review 4.  The genetics of complex cholestatic disorders.

Authors:  Gideon M Hirschfield; Roger W Chapman; Tom H Karlsen; Frank Lammert; Konstantinos N Lazaridis; Andrew L Mason
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

5.  Frequent proviral integration of the human betaretrovirus in biliary epithelium of patients with autoimmune and idiopathic liver disease.

Authors:  W Wang; S Indik; S T Wasilenko; A Faschinger; E J Carpenter; Z Tian; Y Zhang; G K-S Wong; A L Mason
Journal:  Aliment Pharmacol Ther       Date:  2014-12-18       Impact factor: 8.171

6.  Does a betaretrovirus infection trigger primary biliary cirrhosis?

Authors:  Lizhe Xu; Zhiwei Shen; Linsheng Guo; Brent Fodera; Adrian Keogh; Ruth Joplin; Barbara O'Donnell; James Aitken; William Carman; James Neuberger; Andrew Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 12.779

7.  Unique resistance of I/LnJ mice to a retrovirus is due to sustained interferon gamma-dependent production of virus-neutralizing antibodies.

Authors:  Alexandra Purdy; Laure Case; Melody Duvall; Max Overstrom-Coleman; Nilah Monnier; Alexander Chervonsky; Tatyana Golovkina
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.